Aptorum Group Ltd Class A (APM)

US · Healthcare · Biotechnology

—

Latest quarter · ended 2026-06-30

Net profit

$-404,514

Profit YoY

+75.1%

EPS

$-0.04

Market cap

$570,062

Forward P/E

0.0

P/B

0.28

Book value

$28.38

EPS (TTM)

$-1.90

52-week high

$12.24

52-week low

$0.00

50-day MA

$8.64

200-day MA

$10.02

Beta

0.17

Analysts rate Aptorum Group Ltd Class A a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $80.00.

Insiders

16.41%

Institutions

2.47%

Fund	Stake
Citadel Advisors Llc	1.13%
Susquehanna International Group, LLP	0.21%
XTX Topco Ltd	0.18%
Morgan Stanley - Brokerage Accounts	0.16%
Renaissance Technologies Corp	0.15%
Advisor Group Holdings, Inc.	0.07%
UBS Group AG	0.02%
SBI Securities Co Ltd	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aptorum Group Ltd Class A — free to start.

Data updated 2026-09-18.